Wall Street brokerages forecast that Amicus Therapeutics, Inc. (NASDAQ:FOLD) will announce $71.76 million in sales for the current quarter, according to Zacks Investment Research. Three analysts have provided estimates for Amicus Therapeutics’ earnings, with the lowest sales estimate coming in at $70.52 million and the highest estimate coming in at $74.16 million. Amicus Therapeutics posted […]
